Flovent HFA Sales Data

Rank 58 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Flovent HFA U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 58 (11) 13.97% 7.77%
Q3 2013 69 (15) -9.90% -11.73%
Q2 2013 54 (1) -3.99% -7.50%
Q1 2013 53 (6) -0.67% -2.80%
Q4 2012 47 (15) 13.24% 12.95%
Q3 2012 62 (1) -2.46% -1.59%
Q2 2012 61 (5) 0.68% -6.61%
Q1 2012 66 (1) -1.45% -1.66%
Q4 2011 67 (5) 15.06% 16.13%
Q3 2011 72 (3) -10.26% -9.36%
Q2 2011 69 (5) -3.77% -4.60%
Q1 2011 64

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
December 5, 2011More Children Using Preventive Asthma Drugs: Study
Hide
(web4)